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Abstract 
 
There is little research concerning comparisons and com- 
bination of System Dynamics Simulation (SDS) and Agent 
Based Simulation (ABS). ABS is a paradigm used in many 
levels of abstraction, including those levels covered by SDS. 
We  believe that the establishment of frameworks for the 
choice between these two simulation approaches would con- 
tribute to the simulation research. Hence, our work aims for 
the establishment of directions for the choice between SDS 
and ABS approaches for immune system-related problems. 
Previously, we compared the use of ABS and SDS for mod- 
elling agents’ behaviour in an environment with no movement 
or interactions between these agents. We concluded that for 
these types of agents it is preferable to use SDS, as it takes up 
less computational resources and produces the same results 
as those obtained by the ABS model. In order to move this 
research forward, our next research question is: if we intro- 
duce interactions between these agents will SDS still be the 
most appropriate paradigm to be used? To answer this ques- 
tion for immune system simulation problems, we will use, as 
case studies, models involving interactions between tumour 
cells and immune effector cells. Experiments show that there 
are cases where SDS and ABS can not be used interchange- 
ably, and therefore, their comparison is not straightforward. 
 
 
1. INTRODUCTION 
The current scenario in the simulation field presents 
paradigms that allow us to build simulation models for var- 
ious domains. Some of the important simulation approaches 
are System Dynamics Simulation (SDS), Agent-Based Simu- 
lation (ABS), Discrete Event Simulation (DES) and Dynamic 
Systems (DS)[3]. New research also combines these meth- 
ods and defines frameworks for the usage of each paradigm. 
There is already work comparing SDS/DES, DES/ABS as 
well as their combinations. However, there is few research 
on the comparison and combination of SDS and ABS  [8]. 
Hence, our research aims at establishing a framework for 
the development of simulations involving the choice between 
SDS and ABS approaches and their combination for immune 
system-related problems . 
ABS is a paradigm used in many levels of abstraction, in- 
cluding those levels covered by SDS. As there is this inter- 
section, some range of simulation problems can be solved by 
either SDS or ABS. In previous work [1], we compared the 
use of ABS and SDS for modelling static agents’ behaviour 
in an immune system ageing problem. By static we mean that 
there is no movement or interactions between the agents. We 
concluded that for these types of agents, it is preferable to use 
SDS instead of ABS. When contrasting the results of both 
simulation approaches, we see that SDS is less complex and 
takes up less computational resources, producing the same re- 
sults as those obtained by the ABS model. 
To advance this study, our next inquiring is: Once we have 
established that SDS is more suitable for static agents than 
ABS, if we introduce interactions between these agents will 
SDS still be the most appropriate paradigm to be used? 
To answer this question for immune system simulation 
problems, we use models as case studies, which include in- 
teractions between tumour cells and immune effector cells. 
Effector cells are responsible for eliminating tumour cells in 
the organism. Our goal is to determine which scenarios for 
immune system simulations inside the SDS/ABS intersection 
would benefit from SDS resources and those that are more 
suitable for ABS. 
For SDS we need to establish mathematical equations that 
determine the flows. Therefore we use the models reviewed 
in [4]. The authors of this study explored existing spatially 
homogeneous mechanistic mathematical models describing 
the interactions between a malignant tumor and the immune 
system. They begin with the simplest (single equation) mod- 
els for tumor growth and proceed to consider greater im- 
munological detail (and correspondingly more equations) in 
steps. For our simulation, we intend to build SDS and ABS 
for two of the most important mathematical models described 
in [4]. We intend to use the mathematical model also as ba- 
sis for the ABS. The idea is to check if the results would be 
similar and if we can use SDS and ABS for our case studies 
interchangeably. 
This work is organized as follows. In Section 2, there is 
the related work relevant to our studies. Section 3 presents 
the mathematical models used for our simulations, as well as 
the simulations we carried out and their results. Finally, in 
Section 4 we draw the conclusions and present future work. 
 
 
2. RELATED WORK 
The theoretical work presented by [3] compares ABS and 
SD conceptually, and discusses the potential synergy between 
them in order to solve problems of teaching decision-making 
processes. The authors explore the conceptual frameworks for 
ABS and SD to model group learning. They show the con- 
ceptual differences between these two paradigms and propose 
their use in a complementary way. They outstand the lack of 
knowledge in multi-paradigm simulation involving SD and 
ABS. 
In [6] and [8], the authors present a cross-study of SD and 
ABS. They define their features and characteristics and con- 
trast the two methods. Moreover, they also present ideas of 
how to integrate both approaches. As a continuation of this 
work, in [7] they present an approach to integrate the SD 
and ABS techniques for supply chain management problems. 
They present some preliminary results, which were not the 
same as the SD simulation alone. Therefore, they propose 
new tests as future work. In their case study, they were not 
able to reach the same results with both simulations. 
In [9], the authors show the application of both SD and 
ABS to simulate non-equilibrium ligand-receptor dynamics 
over a broad range of concentrations. They concluded that 
both approaches are powerful tools and are also complemen- 
tary. In their case study, they did not indicate a preferred 
paradigm, although intuitively SD is an obvious choice when 
studying systems at a high level of aggregation and abstrac- 
tion. On the other hand, SD is not capable of simulating re- 
ceptors and molecules and their individual interactions, which 
can be done with ABS. 
Rahmandad and Sterman  [5] compare the dynamics of a 
stochastic ABS model with those of the analogous determin- 
istic compartment differential equation model for contagious 
disease spread. The authors convert the ABS into a differ- 
ential equation model and examine the impact of individual 
heterogeneity and different network topologies. The deter- 
ministic model yields a single trajectory for each parameter 
set, while stochastic models yield a distribution of outcomes. 
Moreover, the differential equation model and ABS dynam- 
ics differ for several metrics relevant to public health. The re- 
sponse of the models to policies can also differ when the base 
case behaviour is similar. Under some conditions, however, 
the differences in means are small, compared to variability 
caused by stochastic events, parameter uncertainty and model 
boundary. 
In our previous work [1], we compared SDS and ABS for a 
naive T cell output model. In that study, we concluded that for 
that case study SDS is more suitable. We had a scenario where 
the agents had no interactions and SDS and ABS produced 
similar outputs. Therefore, we decided that, in this case, it is 
preferable to choose the SDS, as it takes up less computa- 
tional resources. In order to continue the investigation, which 
compares these two simulation approaches, we will add inter- 
actions between agents and compare the results. The descrip- 
tion of the problem, as well as the mathematical equations 
can be seen in the next section. 
 
3. MATHEMATICAL MODELS 
In this section, we present mathematical models used as 
basis for our simulations. The simplest ones involve only one 
equation and defines mathematical rules for tumour growth 
(Section 3.1.). The second mathematical model addresses the 
interactions between tumour cells and immune effector cells. 
This is shown in Section 3.2.. 
 
3.1. One-Equation Models: Tumour Growth 
In this section, we present the simplest mathematical mod- 
els. They have only one equation that describes how tumours 
grow. There are three models of tumour growth from [4] con- 
sidered in this study: the logistic model, the von Bertalanffy 
model and the Gompertz model. 
According to [4], the most general equation describing the 
dynamics of tumor growth can be written as: 
 
dT 
dt  = T f (T ), (1) 
where: 
 
• T is the tumour cell population at time t , 
• T (0) > 0, 
• f (T ) specifies the density dependence in proliferation 
and death of the tumour cells. The density dependence 
factor can be written as: 
 
 
f (T ) = p(T ) − d(T ),  (2) 
 
where: 
 
• p(T ) defines tumour cells proliferation, 
• d(T ) define tumour cells death. 
 
The expressions for p(T ) and d(T ) are generally defined 
by power laws: 
 
p(T ) = aT  , (3) 
 
d(T ) = bT  ,  (4) 
For our experiments, we defined the values for and 
using the three well established models: 
Logistic Model: = 0 and = 1 (a, b > 0 and b < a for 
growth), 
will be used for our next simulation set of experiments using 
a two-equation model. 
 
von Bertalanffy Model: = 
a for growth), 
 
 1 and   = 0 (a, b > 0 and b < As the outcomes for ABS are stochastic, we ran each sim- 
ulation for 50 times and the mean simulation output is pre- 
sented. For both simulations, we defined the initial values for 
Gompertz Model:  p(T ) = a and d(x) = b ln(T ) (a, b > 0 
and eb  > a for growth). 
 
 
3.1.1.   SDS for the One-Equation Model 
We have implemented the one-equation models using SDS. 
Figure 1 shows the stock and flow diagram used for modelling 
the mathematical equations. From the SDS perspective, the 
amount of tumour cells is a stock that will be modified by 
proliferation and death flows. 
 
 
 
Figure 1.  SDS diagram for the general one-equation mathe- 
matical model. 
 
 
 
3.1.2.   ABS for the One-Equation Model 
 
 
 
Figure 2.  One equation agent. 
 
We have also implemented the one-equation model using 
ABS. In this case we have a tumour cell agent that will repro- 
duce and die, as it can be seen in Figure 2. 
 
 
3.1.3.   Experiments 
We carried out two experiments to compare the SDS and 
ABS simulation outputs. For the first experiment, we have 
established a variable c, which represents the ratio between a 
and b. The purpose of c is to observe the impact of a and b 
on the tumour growth curve. Therefore, we set c as 5, 2.5, 1.7 
and 1.25. 
In the second experiment, we defined a = 1.636 and b ∈ 
{0.002, 0.005}. These values were determined in [2] and they 
tumour cells equal to 1. 
 
 
 
3.1.4.   Results 
For the first experiment, as is shown in Figure 3 (middle 
and bottom), the outputs for both simulation approaches are 
similar for the von Bertalanffy and Gompertz models. For the 
logistics model, on the other hand, the results of the ABS did 
not match the SDS ones (Figure 3 top). This can be explained 
by the stochastic and individual behaviour of the agents in the 
ABS model. 
In the experiments, there are few agents on the logistics 
model and most of them die before they reproduce. In this 
ABS model, the reproduction rate is given by p(T ) = a, be- 
cause al pha = 0 for the logistics model. In the case where 
a = 1 and b = 0.2, for example, when the number of agents 
becomes bigger than 5, d(T ) gets greater than p(T ). As for 
ABS the death rate is defined for the agents individually, all 
the newborn tumour cells after 5 agents in the system will 
have death rates bigger than reproduction rates. Hence, the 
agents population disappears over the first days. This differ- 
ence on the SDS and ABS results lead us to conclude that 
there are cases using static agents where SDS and ABS out- 
puts will not be the same. 
Nevertheless, if we increase the difference between the pa- 
rameters a and b, as is shown in Figure 4, we avoid the pre- 
mature death of the tumour agents and therefore the ABS and 
SDS results become similar again. From what we have found 
on the literature, the Logistics model is one of the most used 
for average tumours whereas the von Bertalanffy and Gom- 
pertz models are used for more aggressive tumours. There- 
fore, as we increase in the difference between a and b, the 
Gompertz and von Bertalanffy models growth will present a 
considerable increase on the proliferation of tumour cells, as 
illustrates Figure 5. 
Therefore, we could not carry out experiment two using 
ABS for Gompertz and von Bertalanffy models. From the 
SDS results, we can see that the number of tumour cells by- 
passes the magnitude of 1064   in the Gompertz model (Fig- 
ure 3). To run the same experiment with ABS we would need 
more computational resources and it would take up more pro- 
cessing time. In our case, as each agent takes up around 1 
megabyte of memory, we would need a memory capacity of 
1064  megabytes. Therefore, in this case it is preferable to run 
the simulation using SDS, even though such big number of 
tumour cells also seems to be unrealistic in tumour biology. 
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Figure 3.  Results for the one-equation model using SDS and ABS. 
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Figure 4.  Results for the second experiment of one-equation Logistics model using SDS and ABS. 
 
 
3.2. Two-Equation  Models:  Interaction  Be- 
tween Tumour Cells and Generic Effector 
 
dE 
= pE 
 
(T, E ) − dE 
 
(T, E ) − aE 
 
 
(E ) +  (T ),  (6) 
Cells 
To add complexity to our model, we are going to consider 
tumour cells growth together with their interactions with gen- 
eral immune effector cells. In this stage we are not yet con- 
sidering specific types of immune cells. Effector cells are re- 
sponsible for killing the tumour cells. They proliferate and 
die per apoptosis, which is a programmed cellular death. In 
the models, cancer treatment is also considered. 
The interactions between tumour cells and immune effec- 
tor cells can be defined by the equations: 
 
dT 
dt  = T f (T ) − dT (T, E ) (5) 
dt
 
where: 
 
• T is the number of tumour cells, 
• E is the number of effector cells, 
• f (T ) is the growth of tumour cells, 
• dT (T, E ) is the number of tumour cells killed by effector 
cells, 
• pE (T, E ) is the proliferation of effector cells, 
• aE (E ) is the death (apoptosis) of effector cells. 
Scenario    
1 0.002 0.1908 0.318 
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Figure 5.  Results for the second experiment of one-equation 
Gompertz and Von Bertalanffy models using SDS. 
 
 
• (T ) is the treatment or influx of cells. 
 
For our models, we used the Kuznetsov model [2]: 
 
f (T ) = a(1 − bT ),  (7) 
 
 
dT (T, E ) = nT E , (8) 
 
pT E 
pE (E , T ) = g + T , (9) 
 
dE (E , T ) = mT E , (10) 
 
 
aE (E ) = dE , (11) 
 
(t ) = s. (12) 
As it can be seen, the Logistic model was adopted for tu- 
mour growth. It seems to be the most common model of tu- 
mour growth used in the mathematical models involving can- 
cer and the immune system. The values for the parameters on 
the equations can be seen in Table 1. We got these values from 
[4]. In the first three scenarios we consider cancer treatment. 
The fourth case does not consider any treatment. 
 
3.2.1.   SDS for the Two-Equation Model 
We have converted the mathematical model into a SDS 
model. Figure 6 shows the stock and flow diagram we have 
defined. 
We consider two stocks, the tumour cells and the immune 
effector cells. The tumour cell stock is changed by prolifera- 
tion and natural death (as defined in the one-equation model 
in Section 2.1); and death caused by the immune effector 
 
 
Table 1.  Simulation parameters for different scenarios. For 
the other parameters, the values are the same in all experi- 
ments, i.e, a = 1.636, g = 20.19, m = 0.00311 ,n = 1 and 
p = 1.131. 
 
 
 
cells. The immune cells stock is changed by death, apopto- 
sis, proliferation and injection of new cells as treatment. The 
number of tumour cells in the organism also stimulates the 
proliferation of immune cells. 
 
 
 
Figure 6.  SDS diagram for the two-equation mathematical 
model. 
 
 
 
3.2.2.   ABS for the Two-Equation Model 
For the ABS model, we defined two agents that will in- 
teract with each other: the tumour cell agent and the effector 
cell agent. Figure 7 shows the state charts for the effector cells 
and the tumour cells. The state chart for the effector cells (left 
hand side of Figure 7) has two states. Either the cell is alive 
and able to reproduce or is dead. Effector cells can die by nat- 
ural means or by damage. The tumour cells state chart also 
has two states. Tumour cells can reproduce, die with age or 
die killed by effector cells. The rates defined in the transitions 
are the same of the mathematical model. 
 
 
3.2.3.   Experiments 
As we mentioned before, we carried out four experiments 
for the two-equation model. The parameter variation for the 
experiments is shown in Table 1. In the four scenarios, it is 
considered differences in the death rate of tumour cells (de- 
fined by the parameter b), effector cells apoptosis rate (de- 
fined by the parameter d) and treatment (parameter s). 
Similar to the one-equation model, we ran the simulation 
  
Figure 7.  ABS diagram for the two-equation mathematical 
model. On the left hand side we have the state chart for the 
effector cell agents and on the right hand side we have the 
state chart for the tumour cell agents. 
 
 
for the ABS 50 times and display the mean values as the re- 
sults. 
 
 
3.2.4.   Results 
The results comparing SDS and ABS for the four experi- 
ments can be seen in Figure 8 (first and second columns). 
For the first scenario, the behaviour of the tumour cells is 
very similar for the SDS and ABS results. However, when 
we ran the Wilcoxon test for the tumour cells outcome, it re- 
jected the similarity hypothesis for both outcomes, as shown 
in Table 2. This might be due to the fact that the tumour 
cells for the SDS model decrease in an asymptotic way to- 
wards to zero, while ABS behaviour is discrete and hence, it 
reaches zero. The number of effector cells for both simula- 
tions follows the same pattern, although the numbers are not 
the same. The variances in the ABS curve were expected due 
to its stochastic character. 
The results for the second scenario seem to be similar for 
effector cells, although the Wilcoxon test rejects this hypoth- 
esis. The results for the tumour cells are not the same. 
For scenarios 3 and 4, the results are completely differ- 
ent for both simulation approaches. Moreover, when we look 
at the tumour cells curve, the differences are even more evi- 
dent. In scenario 3 using SDS, tumour cells decrease as effec- 
tor cells increase, following a predator-prey trend curve. This 
output is what would be expected by the mathematical model. 
On the other hand, for the ABS, the number of effector cells 
decreases until a value close to zero while the tumour cells 
numbers vary in time differently from the SDS results. The 
predator-prey behaviour is not observed in this experiment. 
In scenario 4, although effector cells seem to decay in a 
similar trend for both approaches, the results for tumour cells 
are completely different. In the SDS simulation, the num- 
bers of tumour cells reach a value close to zero after twenty 
days and then increases again. For the ABS simulation, on 
the other hand, tumour cells reach zero and never increase 
again. It happens because SDS deals with continuous stocks 
and ABS has a discrete number of agents. 
The results in these experiments show that there are sim- 
ulation cases where SDS and ABS derived from the same 
mathematical model do not have the same output. Therefore, 
it is not possible to compare which approach would be more 
suitable for these cases. 
One alternative would be the development of an ABS so- 
lution, which is not based on the rates defined in the math- 
ematical model. However, it seems that for each output (or 
parameter change on the mathematical model), there should 
be a different ABS implementation. 
For example, if we determine that the number of tumour 
cells should always be bigger than zero in the ABS, for the 
second and fourth scenarios the outputs become closer to the 
SDS, as shown in Figure 8. On the other hand, this constraint 
also changes the first scenario results, which seemed satisfac- 
tory before. For scenario 4, although the outcome with this fix 
do not seem very similar on the beginning of the simulation, 
the steady state has closer values. 
To achieve similar results for scenario 3, we also had to 
determine that the number of effector cells should be bigger 
than zero. The results are shown in line 4 of Figure 8. For 
scenario 3 the fix did not work perfectly. It seems that only 
the steady state of the simulation has closer results. We also 
tried to randomly add some effector cells over time, but the 
results did not looked similar as well. 
 
 
4. CONCLUSIONS 
The current scenario in the simulation field presents 
paradigms that allow us to build simulation models for var- 
ious domains. New research compares simulation methods 
and defines frameworks for the usage of each paradigm. How- 
ever, there is few research on the comparison and combina- 
tion of SDS and ABS [8]. We aim at contributing to this area 
by studying immune system simulation problems. Therefore, 
in this study, we used case studies which include interactions 
between tumour cells and immune effector cells. Our goal 
was to determine which scenarios for immune system simu- 
lations inside the SDS/ABS intersection would benefit from 
SDS resources and those that are more suitable for ABS. 
The models we used were reviewed in [4]. We began with 
the simplest (single equation) models for tumor growth and 
proceed to consider tow-equation models involving effector 
and tumour cells. We used mathematical models as basis for 
both ABS and SDS. The idea was to check if the results would 
be similar and if we can use SDS and ABS for our case studies 
interchangeably. 
We carried out two experiments to compare the outputs 
for the one-equation model. For the first experiment, the out- 
puts for both simulation approaches are similar for two cases. 
There was an example, though, where the results of the ABS 
did not match the SDS’s. This is explained by the stochastic 
and individual behaviour of the agents in the ABS model. 
To add complexity to our tests, we considered tumour cells 
Implementation Cells  
    
        
ABS Tumour 
Effector 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABS - Fix 1 Tumour 
Effector 
 
 
 
 
0.0103 
0.4441 
 
 
 
 
 
 
 
 
 
 
ABS - Fix 2 Tumour 
Effector 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Wilcoxon test for tumour cells and effector cells. Comparing the results between SDS and ABS. 
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Figure 8.  Results for the two-equation mathematical model using SDS and ABS. On the first columns we have the SDS results 
for the four scenarios. The second column has the ABS results. The third and fourth columns shows the fixes we tried to make 
the outcomes similar. Fix 1 adds the constraint t umour cells > 0. Fix 2 adds the constraint t umour cells > 0 and e f f ect or 
cells > 0. For each graph we have the results for tumour cells (continuous line) and effector cells (dotted lines). The scale for 
the tumour cells results is on the left y axis of each graph while the scale for effector cells is in the right y axis. 
 
 
growth together with their interactions with general immune 
effector cells. We defined four scenarios and, for only one of 
them, the results were similar using the mathematical model. 
The differences in the output are due to the fact that effector 
cells numbers change continuously on the SDS, while for the 
ABS, they change in a discrete pattern. 
The results in these experiments show that there are sim- 
ulation cases where SDS and ABS derived from the same 
mathematical model do not have the same output. Therefore, 
it is not possible to compare which approach would be more 
suitable for these cases. 
 
One alternative would be the development of an ABS so- 
lution, which is not based on the rates defined in the math- 
ematical model. However, it seems that for each output (or 
parameter change on the mathematical model), there should 
be a different ABS implementation. 
 
As future work we intend to work with models with three 
an four equations and compare the results of SDS and ABS 
without using the mathematical equation as baseline. 
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